Mechanisms of Electrical Activation and Conduction in the Gastrointestinal System: Lessons from Cardiac Electrophysiology

Abstract

The gastrointestinal (GI) tract is an electrically excitable organ system containing multiple cell types, which coordinate electrical activity propagating through this tract. Disruption in its normal electrophysiology is observed in a number of GI motility disorders. However, this is not well characterized and the field of GI electrophysiology is much less developed compared to the cardiac field. The aim of this article is to use the established knowledge of cardiac electrophysiology to shed light on the mechanisms of electrical activation and propagation along the GI tract, and how abnormalities in these processes lead to motility disorders and suggest better treatment options based on this improved understanding. In the first part of the article, the ionic contributions to the generation of GI slow wave and the cardiac action potential (AP) are reviewed. Propagation of these electrical signals can be described by the core conductor theory in both systems. However, specifically for the GI tract, the following unique properties are observed: changes in slow wave frequency along its length, periods of quiescence, synchronization in short distances and desynchronization over long distances. These are best described by a coupled oscillator theory. Other differences include the diminished role of gap junctions in mediating this conduction in the GI tract compared to the heart. The electrophysiology of conditions such as gastroesophageal reflux disease and gastroparesis, and functional problems such as irritable bowel syndrome are discussed in detail, with reference to ion channel abnormalities and potential therapeutic targets. A deeper understanding of the molecular basis and physiological mechanisms underlying GI motility disorders will enable the development of better diagnostic and therapeutic tools and the advancement of this field.

Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis

“…In this condition, there is an ongoing cardiomyopathic process of the atrial myocardium, involving a number of cellular and molecular mechanisms revolving around inflammation . One of the consequences is fibrosis, characterized by increased turnover of the extracellular matrix, producing conduction abnormalities that provide the necessary substrate for arrhythmogenesis . A number of blood biomarkers and electrocardiographic predictors have been found in association with AF onset, development, and recurrence.…”

Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts

“…The mechanisms of arrhythmogenesis have been studied using animal models as they permit the use of genetic or pharmacological manipulation to study the consequences of ion channel abnormalities (19,20,22,23,44–46). In the present study, arrhythmogenic effects of hyperkalemia were examined in Langendorff-perfused mouse hearts.…”

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice

“…Defects in linking sites of these proteins can interrupt cell adhesion, especially under conditions of increased mechanical stress or stretch, leading to cell death, progressive loss of myocardium, and fibro‐fatty replacement . As such, surviving myocardial fibers within the fibro‐fatty tissue from zones of slow conduction provide a medium for re‐entry ventricular arrhythmias . The degeneration‐inflammation model posits that the resulting cellular damage is found in tissues under high mechanical stress .…”